Liquid biopsies in breast cancer: an interview with Michail Ignatiadis

Written by Jade Parker and Mike Gregg, Future Science Group

We recently had the opportunity to interview Michail Ignatiadis (Jules Bordet Institute, Brussels, Belgium) about his research into liquid biopsies. He provides an important insight into the potential of liquid biopsies and their future as a clinical tool, as well as highlighting the important work that still needs to be done to ensure their success. Ignatiadis also discusses his own research in which he uses circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) to monitor and potentially improve the outcomes for metastatic breast cancer patients; as well as providing a round-up of the presentations and data he found most...

To view this content, please register now for access

It's completely free